Methotrexate in the management of Crohn’s disease: A practice survey of gastroenterologists in France

Figure 3 Key factors influencing the practical use of injectable methotrexate in Crohn’s disease management. A: Responses from methotrexate (MTX) non-prescribers; B: Responses from MTX prescribers. The question posed was: “When the prescription of injectable MTX is medically justified, what additional elements would you need to use this product (on a scale from 0 = unnecessary to 5 = essential)?”. Results illustrate clinicians’ perceived practical requirements to facilitate the use of injectable MTX, such as patient education, administrative support, or enhanced clinical guidelines.